Commercialization of SciDAP, a next generation universal platform for collaborative data analysis
SciDAP 的商业化,下一代协作数据分析通用平台
基本信息
- 批准号:10338010
- 负责人:
- 金额:$ 5.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:BiologyBusinessesCollaborationsComputer AnalysisDNA MethylationDNA-Protein InteractionDataData AnalysesDiseaseEnsureEnvironmentGene Expression ProfilingHealthInstructionLanguageLifeMethodsMethylationModelingOutputReproducibilityResearchSPT6 ProteinScientistSystemTestingVisualizationWorkbasebioinformatics toolbiomedical scientistbisulfite sequencingcommercializationcomputational pipelinesflexibilitygenomic datagraphical user interfaceinsightmultiple omicsnext generationnext generation sequencingnovelportabilityprototyperecruitsingle-cell RNA sequencingskillstoolusabilityuser-friendly
项目摘要
Summary
The recent proliferation of next-generation sequencing (NGS) - based methods for the analysis of gene
expression, chromatin structure and protein-DNA interactions has created tremendous opportunities for gaining
novel insights into basic biology, health, and disease. However, analysis of the resulting data requires
computational expertise that many traditional biologists do not possess. Hence, when dealing with genomics
data, majority of biologists require the help of bioinformaticians even for simple tasks. This places these exciting
methods beyond the reach of the majority of life scientists.
This proposal from DATIRIUM, LLC, a start-up company from Cincinnati, OH describes a plan to create SciDAP
(Scientific Data Analysis Platform), a novel multi-omics user-friendly data analysis platform to allow biologists
to analyze the data themselves and to enable collaboration between biologists and bioinformaticians.
We hypothesize that we can create a data analysis platform that is both universal and user-friendly by including
interface instructions into computational pipelines itself. Platform will use these instructions to create a
graphical interface for users. Specifically, we are using containerized pipelines developed using Common
Workflow Language (CWL). CWL allows to describe tools, pipelines and computational environment making
these pipelines both portable and reproducible. On top of CWL, Datirium developed a system of CWL extensions
that allows to describe the inputs and outputs visualizations within the CWL workflows. Importantly, our
platform will increase the rigor of computational analysis by (i) making the analysis reproducible and auditable
by bioinformaticians due to CWL pipeline portability and recording each step of the analysis as Research Objects;
(ii) enabling collaboration between experimentalists and computational biologists by providing
bioinformaticians with a way to direct analysis flow and biologists with the convenience of GUI; (iii) Including
out of the box pipelines with optimized parameters and actionable QC metrics that flag possible issues.
In the first aim of this proposal, we will create a prototype of the platform. In the second aim, we will conduct
usability testing with bioinformaticians and experimentalists to test whether our platform can accommodate
diverse types of the analysis in a user-friendly fashion. Specifically, in collaboration with Dr. Salomonis at
CCHMC, we will test how easy it is to integrate two existing analysis routines into SciDAP: BS-Seq DNA-
methylation and scRNA-Seq; then we will work with biologists to ensure that the resulting interface is both user-
friendly and enables collaboration with bioinformaticians.
In this iCorps supplement, Datirium recruited Amy Duncan, MBA, a commercialization expert specializing in
launch of research products to work with us on developing a a comprehensive, effective, and multi-faceted
commercialization and launch plan. Specifically, we hope to gain the skills and information necessary to
thoroughly understand our varied groups of potential customers and partners and to validate (or modify) our
business model and technical solutions. To this end, we will embark on extensive research about how the
interviewees will receive our product and test our initial plans for commercialization.
摘要
最近基于下一代测序(NGS)的基因分析方法的激增
表达、染色质结构和蛋白质-DNA相互作用为获得
对基础生物学、健康和疾病的新见解。然而,对结果数据的分析需要
许多传统生物学家不具备的计算专业知识。因此,在处理基因组学时
数据,大多数生物学家甚至需要生物信息学家的帮助来完成简单的任务。这使得这些令人兴奋的
这些方法超出了大多数生命科学家的能力范围。
这份来自俄亥俄州辛辛那提市初创公司DATIRIUM,LLC的建议书描述了一个创建本网站的计划
(科学数据分析平台),一个新颖的多组学用户友好的数据分析平台,允许生物学家
分析数据本身,并实现生物学家和生物信息学家之间的合作。
我们假设我们可以通过以下方式创建一个既通用又用户友好的数据分析平台
将指令接口到计算管道本身。Platform将使用这些说明创建
为用户提供图形界面。具体地说,我们正在使用使用Common开发的集装箱化管道
工作流语言(CWL)。CWL允许描述工具、管道和计算环境的生成
这些管道既可携带又可重复使用。在CWL之上,Datirium开发了CWL扩展系统
这允许描述CWL工作流中的输入和输出可视化。重要的是,我们的
平台将通过以下方式提高计算分析的严谨性:(I)使分析可重现和可审计
由生物信息学家由于CWL管道的便携性而记录分析的每一步作为研究对象;
(2)通过以下方式促进实验学家和计算生物学家之间的合作
具有引导分析流程的方法的生物信息学家和具有图形用户界面便利性的生物学家;
开箱即用的管道,具有优化的参数和可操作的质量控制指标,可标记可能的问题。
在本提案的第一个目标中,我们将创建该平台的原型。在第二个目标中,我们将进行
与生物信息学家和实验者一起进行可用性测试,以测试我们的平台是否能够
以用户友好的方式进行多种类型的分析。具体地说,与Salomonis博士在
CCHMC,我们将测试将两个现有的分析例程集成到SciDAP中有多容易:bs-Seq DNA-
甲基化和scRNA-Seq;然后我们将与生物学家合作,确保得到的界面既是用户-
友好并支持与生物信息学家的合作。
在ICorps的这份增刊中,Datirium聘请了MBA艾米·邓肯,她是一名商业化专家,专门从事
推出研究产品,与我们共同开发一个全面、有效、多方面的
商业化和推出计划。具体地说,我们希望获得必要的技能和信息
彻底了解我们不同的潜在客户和合作伙伴群体,并验证(或修改)我们的
商业模式和技术解决方案。为此,我们将展开广泛的研究,研究如何
受访者将收到我们的产品,并测试我们最初的商业化计划。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preparation of mouse pancreatic tumor for single-cell RNA sequencing and analysis of the data.
- DOI:10.1016/j.xpro.2021.100989
- 发表时间:2021-12-17
- 期刊:
- 影响因子:0
- 作者:Surumbayeva A;Kotliar M;Gabitova-Cornell L;Kartashov A;Peri S;Salomonis N;Barski A;Astsaturov I
- 通讯作者:Astsaturov I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Artem Barski其他文献
Artem Barski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Artem Barski', 18)}}的其他基金
Epigenetic mechanisms of disrupted neurodevelopment in Menke-Hennekam syndrome
Menke-Hennekam 综合征神经发育障碍的表观遗传机制
- 批准号:
10816703 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
An experimentally-refined, dynamic gene regulatory network model of T-cell memory
经过实验改进的 T 细胞记忆动态基因调控网络模型
- 批准号:
10576265 - 财政年份:2021
- 资助金额:
$ 5.2万 - 项目类别:
An experimentally-refined, dynamic gene regulatory network model of T-cell memory
经过实验改进的 T 细胞记忆动态基因调控网络模型
- 批准号:
10210685 - 财政年份:2021
- 资助金额:
$ 5.2万 - 项目类别:
An experimentally-refined, dynamic gene regulatory network model of T-cell memory
经过实验改进的 T 细胞记忆动态基因调控网络模型
- 批准号:
10368121 - 财政年份:2021
- 资助金额:
$ 5.2万 - 项目类别:
An experimentally-refined, dynamic gene regulatory network model of T-cell memory
经过实验改进的 T 细胞记忆动态基因调控网络模型
- 批准号:
10213550 - 财政年份:2020
- 资助金额:
$ 5.2万 - 项目类别:
Death-Seq, a Method for Genome-wide Identification of Functional Silencer Elements
Death-Seq,一种全基因组识别功能性沉默元件的方法
- 批准号:
9979291 - 财政年份:2020
- 资助金额:
$ 5.2万 - 项目类别:
SciDAP: a next generation universal platform for collaborative data analysis
SciDAP:下一代协作数据分析通用平台
- 批准号:
10081764 - 财政年份:2020
- 资助金额:
$ 5.2万 - 项目类别:
相似海外基金
The effectiveness of public support for high-potential businesses
对高潜力企业的公共支持的有效性
- 批准号:
ES/Z50256X/1 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Research Grant
Inclusive Employment - Innovating Businesses
包容性就业 - 创新企业
- 批准号:
10105452 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Collaborative R&D
An empirical analysis of the relationship between strategic actions in response to uncertainty in family businesses and performance
家族企业应对不确定性的战略行动与绩效关系的实证分析
- 批准号:
23K01459 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Impact of Natural Disasters on Businesses and Consumers
自然灾害对企业和消费者的影响
- 批准号:
2242349 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Standard Grant
Risk management through portfolio optimization of resource and non-resource businesses in companies
通过公司资源和非资源业务的投资组合优化进行风险管理
- 批准号:
23K12543 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Improving the international competitiveness of SMEs: Creating synergies between overseas M&A management and domestic businesses
提升中小企业国际竞争力:发挥海外中小企业协同效应
- 批准号:
23K12530 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CyberSecurityAId: Empowering Small Businesses with Cyber Hygiene
CyberSecurityAId:为小型企业提供网络卫生保障
- 批准号:
10098244 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Collaborative R&D
AI ideation for creative businesses
创意企业的人工智能创意
- 批准号:
10078276 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Collaborative R&D
Assessing managerial sensemaking processes of businesses with biodiversity issues
评估具有生物多样性问题的企业的管理意义建构过程
- 批准号:
2783455 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Studentship
An Empirical Study on Existence and Effectiveness of Stakeholder-oriented Farm Businesses in Less-favoured Areas in Japan
日本欠发达地区利益相关者导向农场企业的存在性和有效性的实证研究
- 批准号:
23K14032 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists